The ACUTE trial. Transesophageal echocardiography to guide electrical cardioversion in atrial fibrillation. Assessment of Cardioversion Using Transesophageal Echocardiography

Cleve Clin J Med. 2002 Sep;69(9):713-8. doi: 10.3949/ccjm.69.9.713.

Abstract

The Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) trial compared cardioversion following transesophageal echocardiography (TEE) against conventional management of atrial fibrillation (ie, cardioversion following 3 weeks of anticoagulation) in patients scheduled to undergo electrical cardioversion.

Publication types

  • Review

MeSH terms

  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / complications
  • Atrial Fibrillation / therapy*
  • Clinical Protocols
  • Combined Modality Therapy
  • Decision Trees
  • Echocardiography, Transesophageal*
  • Electric Countershock / adverse effects
  • Electric Countershock / methods*
  • Embolism / etiology
  • Embolism / prevention & control
  • Humans
  • Outcome Assessment, Health Care
  • Randomized Controlled Trials as Topic
  • Thrombosis / etiology
  • Thrombosis / prevention & control
  • Time Factors
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Warfarin